Home » Newsletters » BioWorld Science

BioWorld Science

March 25, 1998

View Archived Issues

FK-506: a topical agent for the treatment of moderate to severe atopic dermatitis

Photogen announces results from animal studies on activation process of photodynamic agents

PPL reports expression of FIX at high concentrations in milk of transgenic sheep

New antiasthmatic agents claimed by Byk Gulden

Life Medical Sciences receives FDA approval to begin Repel-CV trials

Method of detecting HAV infection available for licensing from NIH

Progenitor, CAT establish gene-to-clinic collaboration

Isis and Zeneca collaborate on oligonucleotide manufacturing; fomivirsen filing in sight

Coulter completes patient enrollment in Bexxar phase III trial

PathoGenesis seeks Canadian approval for TOBI in CF

CTL establishes antigen discovery collaboration with University of Tubingen

Compounds with high binding affinity for the 5-HT7 receptor described by Meiji Seika

New antitumor agents discovered by Toagosei

Antiplatelet agents disclosed by Nippon Steel

Selective factor Xa inhibitors in development at Banyu

Spotlight on dual-action ACE/NEP inhibitors

New agents for PDT reported by Yeda

CytoMed and UCB join forces to develop antiinflammatory therapeutics

Salix Holdings name change

ST-630 successfully completes phase Ia trial for osteoporosis

Hoechst discovers inhibitors of various inflammatory mediators

New retinoid-like compounds discovered at Allergan

NIH will license out new technology for studying bone metabolism

Angiogenesis-inhibitory monokine available for licensing from NIH

Novel treatment for red blood cell disorders available for licensing

Ribozyme, Parke-Davis collaboration confirmed

Synaptic licenses technology for BPH treatment to Glaxo Wellcome

UPMC leads the way in gene therapy for musculoskeletal disorders

UPMC studies feasibility of gene therapy for osteoporosis

Gene therapy for treating growth hormone deficiencies

VEGF gene medicine incorporating DOTMA enters phase II testing

Neurogen describes treatment for stress-related disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...